Editorial
Published on 07 Sep 2023
Editorial: Chemokine receptors and signaling in wound healing
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1282233
- 1,233 views
Type at least 3 characters
1,653 articles
Articles
Review
Published on 07 Sep 2023
Novel potential pharmacological applications of dimethyl fumarate—an overview and update
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1264842
- 7,145 views
- 13 citations
Original Research
Published on 04 Sep 2023
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1183720
- 3,018 views
- 3 citations
Original Research
Published on 29 Aug 2023
Aspirin eugenol ester ameliorates LPS-induced inflammatory responses in RAW264.7 cells and mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1220780
- 3,107 views
- 4 citations
Original Research
Published on 29 Aug 2023
Dasatinib suppresses particulate-induced pyroptosis and acute lung inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1250383
- 3,057 views
- 1 citation
Mini Review
Published on 28 Aug 2023
A glimpse of the connection between PPARÎł and macrophage
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1254317
- 4,064 views
- 7 citations
Review
Published on 25 Aug 2023
Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1263839
- 2,763 views
- 1 citation
Review
Published on 24 Aug 2023
Recent advances in JAK inhibitors for the treatment of metabolic syndrome
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1245535
- 5,619 views
- 6 citations
Original Research
Published on 23 Aug 2023
Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1219160
- 2,829 views
- 5 citations
Editorial
Published on 21 Aug 2023
Editorial: Autophagy in inflammation related diseases, volume II
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1273511
- 1,035 views
Review
Published on 21 Aug 2023
Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1219690
- 3,262 views
Correction
Published on 17 Aug 2023
Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-ÎşB pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1236892
- 1,330 views
Review
Published on 17 Aug 2023
Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1255727
- 2,284 views
- 3 citations
Opinion
Published on 17 Aug 2023
Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228359
- 1,096 views
Original Research
Published on 15 Aug 2023
Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1215861
- 2,550 views
- 4 citations
Original Research
Published on 15 Aug 2023
Identification of polyunsaturated fatty acids as potential biomarkers of osteoarthritis after sodium hyaluronate and mesenchymal stem cell treatment through metabolomics
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1224239
- 2,579 views
- 1 citation